Study shows measles can make other antibodies less effective.
An effective HIV vaccine has proven elusive, but a new type of vaccine may provide results.
Enhancing vaccination programs increase revenue and clientele base.
Results of multi-generational study indicates risk reduction potential.
Study shows that efficacy is a major concern.
23,600 cases across 29 states since 2016.
Fear, one's faith in the government, and likelihood of exposure are leading factors.
New changes are making it more difficult for generics and biosimilars to compete on formularies.
Managing post-summer medication changes.
Biotech companies join forces to develop oral flu vaccines.